Drawbridge Health

Drawbridge Health was established in 2015 as a spin-off from GE Ventures and GE Healthcare, with Harry Glorikian listed as a founder. The company aims to transform the blood sampling process. A significant milestone was achieved in August 2019, when the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its OneDraw™ A1C Test System. This was followed by receiving the CE Mark in Europe in February 2020 and winning the Red Dot Award for Product Design later that year.

In May 2021, Thorne HealthTech acquired a majority stake in Drawbridge Health, which now operates as a subsidiary. Lee McCracken, who was recruited as CEO by GE Ventures and has over 30 years of experience in the life sciences and venture capital sectors, transitioned to the role of Chairman of the Board after the acquisition. The company has secured funding through several rounds, with investors including Mitsubishi UFJ Capital, Sumitomo Dainippon Pharma, and Kyoto University Innovation Capital.

Drawbridge Health operates in the diagnostic equipment and healthcare services market, targeting patients, healthcare providers, clinical research organizations, and pharmaceutical companies. The business centers around its flagship product, the OneDraw™ Blood Collection Device. This single-use device is designed to offer a more comfortable alternative to traditional venipuncture. It adheres to the patient's upper arm and uses tiny lancets combined with a light vacuum suction to collect a capillary blood sample. A key feature is the device's ability to stabilize the collected blood sample on a paper matrix within a removable cartridge, which eliminates the need for refrigeration during transport to a certified lab for analysis. This facilitates remote sample collection and allows for shipping via regular mail. The company's revenue is generated from the sale of these devices and test kits, which are currently available as a self-pay option with a healthcare professional's referral.

Keywords: blood collection, diagnostic device, remote sampling, capillary blood, diabetes monitoring, HbA1c testing, blood sample stabilization, patient compliance, home healthcare, clinical trials, GE Ventures spinoff, Thorne HealthTech, OneDraw, medical diagnostics, healthcare technology, pain-free blood draw, remote diagnostics, sample transport, telehealth solutions, diagnostic equipment